Compass Therapeutics, Inc.CMPXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank71
3Y CAGR+37.7%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+37.7%/yr
vs +79.7%/yr prior
Acceleration
-42.0pp
Decelerating
Percentile
P71
Within normal range
vs 3Y Ago
2.6x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$6.35M-12.4%
2024$7.25M-7.9%
2023$7.87M+223.8%
2022$2.43M+912.7%
2021$-299000.00+81.9%
2020$-1.66M-175.5%
2019$-601000.00-357.9%
2018$233000.00-